The pro­tec­tive nu­tri­ent

The Star Malaysia - Star2 - - World Diabetes Day -

AC­CORD­ING to a Health Min­istry re­port ti­tled Screen­ing for Di­a­betic Retinopa­thy, di­a­betic retinopa­thy is the lead­ing cause of blind­ness among adults aged 20 to 70.

Ev­ery di­a­betes pa­tient is at risk of di­a­betic retinopa­thy as pro­longed pe­ri­ods of high blood glu­cose lev­els can dam­age tiny blood ves­sels that nour­ish the retina.

As there are of­ten no symp­toms un­til the dis­ease pro­gresses, di­a­betic retinopa­thy can de­stroy the eye’s blood ves­sels with­out any no­tice­able symp­toms.

Ninety-five per cent of se­vere vi­sion loss from di­a­betic retinopa­thy can be pre­vented by early de­tec­tion, timely treat­ment and ap­pro­pri­ate fol­low-up care.

Di­a­betes pa­tients can lower the risk of di­a­betic retinopa­thy by keep­ing blood glu­cose lev­els un­der con­trol, tak­ing a di­lated eye ex­am­i­na­tion once a year, quit­ting smok­ing and main­tain­ing a healthy life­style. Con­sump­tion of Py­c­nogenol can also pro­vide pro­tec­tion to the eyes.

Py­c­nogenol is a nat­u­ral in­gre­di­ent ex­tracted from the bark of French mar­itime pine trees (Pi­nus pinaster), which grow ex­clu­sively along the coast of south­west France.

Con­sist­ing of highly bioavail­able an­tiox­i­dants called pro­cyani­dins, bioflavonoids and or­ganic acids, Py­c­nogenol helps pro­tect the eyes by neu­tral­is­ing the harm­ful ef­fects of free rad­i­cals. This en­ables the body to heal and re­pair it­self.

Un­treated retinopa­thy may progress to the pro­lif­er­a­tive stage, which is char­ac­terised by growth of new cap­il­lar­ies to com­pen­sate for the lack of oxy­gen sup­ply in the retina. How­ever, the new blood ves­sels are frag­ile, mak­ing them more likely to leak and bleed.

Py­c­nogenol strength­ens reti­nal cap­il­lar­ies to help con­trol leak­age of blood and flu­ids into the retina. It also sup­ports bet­ter blood mi­cro-cir­cu­la­tion in the retina by im­prov­ing the en­dothe­lial func­tion of reti­nal mi­cro ves­sels.

In a multi-cen­tre study ti­tled Py­c­nogenol for di­a­betic retinopa­thy. A re­view. pub­lished in the In­ter­na­tional Oph­thal­mol­ogy in2001,a to­tal of 1,169 sub­jects with type 1 and type 2 di­a­betes were pro­vided with Py­c­nogenol in dosages rang­ing from 20mg to 160mg, de­pend­ing on the sever­ity of reti­nal bleed­ing, for six months.

The out­come of the study showed that af­ter six months, on av­er­age, no fur­ther vi­sion loss oc­curred, sug­gest­ing that Py­c­nogenol ef­fec­tively stops the pro­gres­sion of retinopa­thy.

Be­sides that, vis­ual acu­ity im­proved as soon as af­ter three months of treat­ment and fur­ther im­proved af­ter an­other three months of treat­ment with Py­c­nogenol.

Vis­ual im­pair­ment can sig­nif­i­cantly im­pact a per­son’s daily ac­tiv­ity. Hence, it is im­por­tant es­pe­cially for in­di­vid­u­als with high blood sugar to pro­tect their eyes to prevent the de­vel­op­ment of

di­a­betic retinopa­thy.

This ar­ti­cle is brought to you by BiO-LiFE Mar­ket­ing Sdn Bhd.

For en­quiries, call BiO-LiFE Cus­tomer Care (Mon­day to Fri­day, 8am to 5pm) at 03-7499 7999 or e-mail health@bi­o­life.

Newspapers in English

Newspapers from Malaysia

© PressReader. All rights reserved.